# VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes Mellitus

> **NCT01528254** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 2004 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Placebo of vildagliptin
- **DRUG:** vildagliptin
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01528254
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03-30
- **Primary completion:** 2019-04-04
- **Final completion:** 2019-04-04
- **Target enrollment:** 2004 (ACTUAL)
- **Last updated:** 2020-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01528254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01528254, "VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01528254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*